Additional file 2: of Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
posted on 2019-01-03, 05:00authored byIan Passmore, Anna Andrejeva, Brendan Wren, Jon Cuccui
Figure S1. MS/MS spectrum corresponding to peptide GDDEIYGNDTHDILYGDDGNDVIHGGDGNDHLVGGNGNDR from ApxIA modified with 2 hexose units, showed continuous fragmentation ions, which confirm the peptide identity. However, the modified site could not be conclusively determined. (PDF 142 kb)
Funding
Biotechnology and Biological Sciences Research Council